All Activity

A new public education campaign launched—and then quickly deleted—by Virginia state officials that aimed to discourage marijuana-impaired driving appeared to effectively serve as a commercial advertising the relaxation-enhancing effects of cannabis. The new 30-second spot from the Virginia Department of Motor Vehicles featured minimal narration, simply telling viewers that “if you get high to relax…relax.” Actors were shown on screen engaging in a variety of relaxing and enjoyable activities, such as watching a nature documentary while snacking, taking a soothing bubble bath and tending to plants in a backyard garden. A couple was also shown digging into a huge haul of Chinese take-out food. On-screen text at the end of the ad said, “Don’t drive.” “Through a lighthearted and relatable message, the campaign reminds drivers that cannabis impairment can affect their ability to drive safely and that the best place to unwind is at home, not behind the wheel,” DMV said in a now-deleted press release on the department’s website about the new effort. “DMV’s message is clear: driving is stressful and requires your full attention. Being high makes it harder to react, stay in your lane and handle the unexpected,” it said. “So, if you use cannabis to unwind, do yourself—and everyone else on the road—a favor: stay put…and relaxxxxx.” The campaign was based on research finding that most people who use marijuana do so to relax, the department said. A focus group showed that the concept, developed by DMV’s Highway Safety Office and its creative partner Two Tango Collaborative, “resonated with the target audience before beginning production” of the ad. “Impaired driving is illegal and dangerous, no matter the substance,” DMV Commissioner Saundra M. Jack said. “We want everyone to travel safely. If you use cannabis, please don’t drive.” DMV suggested that people who are under the influence of cannabis use rideshare services or call sober friends to drive them. The new campaign was scheduled to air statewide from August 10 to September 7, including on TV, social and digital media, billboards and radio, according to the press release. There was also set to be a plane flown over concert venues displaying a banner reminding people not to drive while high. The DMV’s official YouTube upload of the video has now been deleted for reasons that are unclear, but a version that was posted to Instagram by The DMV Daily, which tracks local news in Washington D.C., Maryland and Virginia, remains available. A LinkedIn post about the ad from Brandy Brubaker, the director of the Virginia Highway Safety Office, was also deleted. Marijuana Moment reached out to DMV for more information but a representative was not immediately available. Meanwhile, Virginia lawmakers this year enacted legislation to legalize recreational marijuana sales after Gov. Abigail Spanberger (D) suggested amendments to, and then ultimately vetoed, a previous version of the proposal. A coalition of hemp businesses are suing state officials over provisions of the legislation that will impose restrictions on the products they produce and sell. The post Virginia Officials’ PSA On Impaired Driving Highlights Marijuana’s Relaxation-Enhancing Abilities appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Looking for something refined rather than rushed, I decided on Call Girls in Dwarka. The girl was graceful, good at reading the mood, and the time together felt natural and pleasant. No awkward pauses or pushy behaviour. A reliable option if quality matters to you.

We understand that first impressions matter tremendously in this industry, which is why our companions arrive impeccably dressed for every occasion. Whether accompanying you to a business function or joining you for a private dinner, they adapt seamlessly to any setting. The Escorts In Jhandewalan represented by our agency possess natural grace and poise that immediately draws attention while maintaining appropriate decorum in public spaces.

Dr. Oz presses lawmakers on hemp CBD; VA psilocybin trial; TX Senate candidate on marijuana; Square boots hemp & CBD off platform; GA medical cannabis Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Senate rejected an amendment to keep the federal recriminalization of hemp THC products on track for November—instead passing a White House-supported provision to delay the ban to give lawmakers more time to craft a regulatory structure as an alternative to prohibition. Centers for Medicare and Medicaid Services Director Mehmet Oz sent a letter asking senators not to pass the amendment to keep the hemp product ban on track for November—saying he has “grave concerns” it would undermine a Trump administration initiative to cover CBD products through Medicare. The Department of Veterans Affairs is launching a new clinical trial on whether psilocybin can help military veterans who are struggling with treatment-resistant depression, including those who have concurrent PTSD. Texas Democratic U.S. Senate candidate James Talarico said the state keeping marijuana illegal while also banning hemp THC products is an “insane” form of “corruption” that benefits alcohol and tobacco companies and drug cartels. “You’ve got big industries buying politicians and pushing bills that harm people, but benefit them financially.” The point-of-sale and payments service Square said it will no longer allow CBD and hemp to be sold on its platform, citing the forthcoming federal recriminalization of many hemp products. The Rhode Island Cannabis Control Commission launched a new recreational marijuana business licensing process that sets aside slots for social equity applicants and worker-owned cooperatives following the conclusion of litigation that blocked a prior effort. The Georgia Department of Public Health acknowledged delays in processing medical cannabis patient registrations amid a huge influx of applications under the state’s newly expanded law that adds new qualifying conditions, allows vaping of flower and changesTHC potency limits. / FEDERAL Sen. Ron Wyden (D-OR) launched an investigation into what his office called “the Trump administration’s corrupt ties to Big Tobacco and the kratom industry.” Sen. Ted Cruz (R-TX) tweeted, “I support the current hemp language in the funding bill. It bans synthetic intoxicants while giving naturally derived products a short extension. That’s common sense, and it gives Congress and the Administration time to negotiate a more substantial bill.” Rep. Andy Harris (R-MD) criticized the White House’s push to delay the scheduled hemp THC product ban. The House bill to respect state marijuana laws got one new cosponsor for a total of eight. / STATES A new Colorado law on medical cannabis use by terminally ill patients at hospitals takes effect on Wednesday. A California judge ruled that regulators failed to implement a compliant marijuana track and trace system. Separately, regulators announced a recall of marijuana products due to packaging and labeling that is attractive to children. Montana regulators filed proposed changes to rules on operational control of marijuana businesses and disclosure of third-party contractual relationships. New York regulators approved additional marijuana business licenses and discussed recommendations to strengthen community impact plans. They also reaffirmed that equity license holders must maintain sole control over their cannabis businesses. New Jersey regulators took disciplinary action against marijuana businesses over alleged violations. Tennessee regulators posted a list of licensed hemp retailer businesses. Minnesota regulators posted a list of tax-delinquent cannabis businesses. The Massachusetts Cannabis Social Equity Advisory Board will meet on Monday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Boston, Massachusetts Cannabis Board will meet on Wednesday. / SCIENCE & HEALTH A study of oncologists, anesthesiologists and neurologists found that “participants were positive towards [medical cannabis] and believed in its effectiveness in specific diseases and symptoms.” A study of rats found that “CBD exerts a protective effect on memory comparable to standard estrogen therapy, supporting its therapeutic potential for menopause-related cognitive impairments.” / ADVOCACY, OPINION & ANALYSIS The Washington Examiner editorial board urged Congress to keep a hemp THC product ban on track for November. / BUSINESS Trulieve Cannabis Corp. reported quarterly revenue of $271 million and a net loss of $406.1 million. Canopy Growth Corporation reported quarterly net revenue of C$81.2 million and a net loss of C$14.6 million. WM Technology, Inc. reported quarterly revenue of $42.4 million. The law firm Fisher & Phillips LLP published a survey finding that more employers are drug testing job applicants for cannabis than two years ago. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Senate votes to delay hemp THC product ban (Newsletter: August 10, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This sounds like a fantastic gathering! I love the theme, it really brings out the cozy, community vibe. Looking forward to some great conversations and perhaps even a round of Doodle Baseball if anyone's up for it to add a little playful competition. Hope to see you all there for a wonderful time!

Should you desire to check off something from your personal bucket list, hire a Laxmi Nagar Escort. They know how to make your dreams come true by role-playing and fetish acts. Whatever fantasies you have, whether for a single night or a GFE, our Laxmi Nagar models will make them real.

“We understand applicants are eager to receive their cards, and we appreciate their patience as we work through this unprecedented volume.” By Alander Rocha, Georgia Recorder Georgia’s medical cannabis program experienced an unprecedented surge of new registered patients over the past month after the law changed significantly to ease access. The patient registry grew from 36,595 patients in late June to 44,854 on Monday, an increase of more than 22 percent in just over a month. The increase of over 8,200 active patients marks a significant change of pace for a decade-old program that grew sluggishly under the previous law. The steep increase reflects a “pent-up demand” across Georgia, said Gary Long, CEO of Botanical Sciences, one of the state’s medical cannabis producers. Long said that the uptick is encouraging, and he does not expect it to slow down. “We’re in that adoption phase where the word is getting out, and more and more patients are learning about the laws in the state and what they can and can’t do,” Long said Monday. “People are starting to realize that Georgia has evolved its laws, and now if you choose to qualify, and you do qualify, you’re able to get these products as you see fit, from either a dispensary or a pharmacy that is licensed to do so.” Long added that up to 4 percent of people in states with established medical cannabis programs are patients, and with Georgia’s population of nearly 11.5 million, he estimated that 300,000 to 400,000 Georgians could eventually become patients. The new law that went into effect in July eliminated the state’s “low-THC oil” branding and tossed its percentage potency cap, opting for a milligram-based system that is an industry standard. The new framework also allows patients over 21 to purchase products for vaping, but smoking cannabis flower is still prohibited by state law. It also added new qualifying conditions, such as lupus and irritable bowel syndrome, and it gets rid of the requirement that certain conditions, like cancer and AIDS, must be “severe or end stage” to qualify. But the large influx of new patients created a bottleneck for the Department of Public Health (DPH), the agency responsible for verifying and giving patients a medical cannabis card. The agency, which previously took up to a week to verify a patient’s eligibility, is currently experiencing processing times of up to four weeks. “Our team is working diligently to process applications as quickly as possible while ensuring each one is reviewed accurately and in accordance with state requirements. We understand applicants are eager to receive their cards, and we appreciate their patience as we work through this unprecedented volume,” said DPH spokesperson Nancy Shirek. To enroll in Georgia’s medical cannabis program, patients with a qualifying condition must first be evaluated by a DPH-approved doctor. Once evaluated, the doctor submits the patient’s information to the department, which manages the state’s patient registry. After the agency verifies the information, the patient receives a link to pay for their medical cannabis card, which is then shipped to the patient’s address. This story was first published by Georgia Recorder. The post So Many Georgia Patients Are Signing Up For Expanded Medical Marijuana Law That Officials Are Having Trouble Processing Them All appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. prediksi toto macau

Yours is a prime example of informative writing. I think my students could learn a lot from your writing style and your content. I may share this article with them Dewagg Login

“Our focus is to maintain that momentum by implementing the amended Cannabis Act as efficiently as possible.” By Christopher Shea, Rhode Island Current Rhode Island’s Cannabis Control Commission on Friday reopened the application process for prospective retailers after regulators’ first attempt to license more pot shops was halted by a federal court order and voided under a new state law. Gov. Dan McKee (D) on June 10 signed a pair of bills that undo a provision in the original 2022 Rhode Island Cannabis Act that required cannabis retailers be majority-owned by Rhode Island residents, along with kickstarting a new application process within 60 days. They’re changes the state made in order to resolve the trio of federal lawsuits that led to U.S. District Court Judge Melissa DuBose blocking the Cannabis Control Commission from holding the lottery it was planning to hold in May to award licenses. DuBose also stopped regulators from continuing to screen and review any of the 97 retail license applications submitted by the original December 29, 2025, deadline. “Our focus is to maintain that momentum by implementing the amended Cannabis Act as efficiently as possible,” Michelle Reddish, chairperson of the three-member regulatory panel, said in a statement Thursday. The Adult-Use Retail Licensing Portal is now open. Interested in Social Equity Applicant Status Certification? Submit an Interest Form to begin the certification process and review our updated applicant guidance at https://t.co/DZwOPyVORS. pic.twitter.com/MWcBJqTJnc — RI Cannabis Control Commission (@Cannabis_RI) August 7, 2026 Online submissions for the state’s three license types will be accepted through Monday, November 23. Prospective retailers seeking a social equity license, reserved for those adversely affected by the war on drugs, must first receive certification by September 11. The commission’s announcement did not include a timeline for regulators to review applicants nor say when licenses would be awarded. The revised law requires social equity businesses to be majority owned by one or more people who can show they were disproportionately impacted by criminal enforcement of past prohibitions, including being arrested or having a family member who was. Under the 2022 act that legalized recreational cannabis, the commission can offer 24 new licenses to retailers, with six reserved for social equity applicants and another six reserved for worker-owned cooperatives. But not every license type received an application in each of the six geographic zones during the first go, which left regulators with a maximum of 20 licenses to issue across the state. As it stands, nine shops are selling recreational cannabis in Rhode Island under hybrid retail-medicinal licenses grandfathered in from the state’s medical marijuana program. The halt in the state’s first application pool left many would-be business owners continuing to pay rent on storefronts they may not even be able to open. Though they can’t recoup their property costs, the new state law allows those initial applicants to be refunded any fees paid to the commission. All prospective retailers were required to pay an application fee of $7,500 and a yearly $30,000 licensing fee. Fees were waived for the first year for approved social equity applicants. Over half of all applicants—56—sought general retail licenses. Another 19 were worker cooperatives while the remaining 23 were for social equity applicants. Charon Rose, spokesperson for the Cannabis Control Commission, said in an email Friday that refund checks are expected to be issued on a rolling basis beginning next week. She did not state how many of the 75 applicants who paid the original application fee sought refunds. This story was first published by Rhode Island Current. The post Rhode Island Officials Restart Marijuana Business Licensing Process After End Of Litigation That Blocked Prior Effort appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That is the nice tips and hints certainly towards some of those having their first go blogosphere, temporary not to mention adequate information… Thanks a lot for the purpose of showing gas 4 free :. Vital read through piece of writing. situs slot

Maintain the nice perform, My partner and i examine handful of content with this internet site and also I do believe your net website will be genuine intriguing and contains received sectors regarding great details. situs toto

The U.S. Senate has rejected an amendment to make sure that hemp THC products are federally recriminalized on time under a current plan that is set to go into effect in November, instead allowing a provision that would delay the ban to advance. Industry supporters say the move will hopefully give them more time to convince Congress to craft regulations as an alternative to prohibition. The anti-hemp proposal, from Sen. Ted Budd (R-NC) and several cosponsors, sought to strip provisions out of a key spending bill released by Senate leaders over the weekend and supported by the White House that aim to delay the scheduled hemp product ban. The amendment was killed by a motion to table from Sen. Amy Klobuchar (D-MN) that was adopted in a vote of 61-32. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. Last weekend, leaders of the Senate Appropriations Committee released the text of a continuing resolution to extend funding for federal agencies through December 11, past the end of the current fiscal year on September 30. Included in the legislation are provisions that would also delay the planned prohibition on most hemp products until December 11—although there is a carve-out to allow the immediate recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” After Budd’s amendment was rejected, the Senate passed the underlying funding bill that includes the language to delay the ban by a vote of 90-6. Agreed to, 61-32: Klobuchar motion to table Budd amendment #6747 to Cal. #320, H.R.6500, legislative vehicle for a Continuing Resolution. — Senate Cloakroom (@SenateCloakroom) August 8, 2026 Budd argued in a Senate floor speech on Wednesday that widespread availability of intoxicating hemp products in states across the country is a “public health crisis” that threatens the lives of children, harms the workforce and undermines military readiness. “The intoxicating hemp industry wants to make a cheap dollar,” the senator said. “I am appalled at the well-oiled, slick lobbying machine, which is very well connected in this town, by the way, that has chosen to wage this surreptitious war against our efforts to protect American children.” Budd’s amendment garnered a lengthly list of cosponsors, including Sens. Pete Ricketts (R-NE), James Lankford (R-OK), Chuck Grassley (R-IA), Mike Rounds (R-SD), Mitch McConnell (R-KY), John Cornyn (R-TX), Bill Cassidy (R-LA), Tom Cotton (R-AR), Joni Ernst (R-IA), Kevin Cramer (R-ND), Alan Armstrong (R-OK), Kirsten Gillibrand (D-NY), Jim Banks (R-IN) and Thom Tillis (R-NC). Several sources told Marijuana Moment this week that Trump personally called Budd in an attempt to get him to back off the push to keep the hemp ban on track for November, but a spokesperson for the senator later clarified that there was “not an explicit ask made to Sen. Budd to drop the amendment” by the president. The spokesperson said that the hemp issue “certainly came up” during what he described as a “very friendly” discussion between Budd and Trump that also touched on number of other topics. Centers for Medicare and Medicaid Services Director Mehmet Oz sent a letter to senators this week expressing “grave concern” that the amendment would undermine the administration’s initiative to cover hemp-derived products through Medicare. Separately, the White House pushed back on the idea that the president’s support for keeping hemp products legal is intended to benefit the son-in-law of Trump’s chief of staff, who owns businesses in the industry—with a spokesperson saying that the administration’s advocacy is in “the best interest of the American people” and is aimed at helping veterans and other people who use hemp products for medical purposes. During a “tense” meeting with Senate Republicans about the issue on Wednesday, White House Director of Legislative Affairs James Braid reportedly committed that there would be no further extensions of the hemp ban’s effective date if the current proposal was enacted into law. Also this week, dueling coalitions of police, military veterans and industry groups sent letters pushing Congress in different directions on whether the planned federal recriminalization of hemp THC products should move forward as scheduled or be delayed. Additionally, a bipartisan coalition of 35 state and territory attorneys general sent a letter calling on Congress not to reverse the hemp THC product ban, saying that lawmakers’ move to enact the forthcoming prohibition “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.” Meanwhile, the Beverage Alcohol Merchants Coalition (BAMCO), which represents major alcohol retailers, is supporting the move to delay the hemp product ban—saying it provides industry supporters with more time to convince Congress to “establish a responsible federal framework for low-dose hemp-derived THC beverages.” BAMCO’s members include Total Wine & More, BevMo! by Gopuff, ABC Fine Wine & Spirits, Spec’s Wine and Spirits & Finer Foods, as well as a group of hemp product wholesalers. The group supports incorporating hemp THC drinks into the existing three-tier system for alcoholic beverages, along with new requirements for testing, labeling, marketing and taxation in tandem with flexibility for state regulations. Other alcohol industry groups such as Wine & Spirits Wholesalers of America have also backed regulating hemp products instead of prohibiting them. In June, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded into December, but it did not have any provisions to alter the planned hemp product ban. Meanwhile, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products later this year. Until now, none of those proposals have gained traction with congressional leaders. For example, Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. A press release from the congressman’s office claimed that the White House supports the legislation, which is cosponsored by Rep. Angie Craig (D-MN), but the administration has not specifically endorsed it despite generally calling for hemp regulations and backing a prior similar amendment filed by Barr. Trump and White House officials have in recent weeks repeatedly pressed Congress to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) in June, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said in June, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” The Wine & Spirits Wholesalers of America (WSWA), an alcohol industry trade association issued praise for Barr’s bipartisan hemp regulation bill, but said the measure’s tax provisions require “continued discussion.” Hemp policy observers expect to see a Senate companion bill to Barr’s proposal filed soon, likely from Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN). Sheehy recently cited hemp legislation as an area where Republicans and Democrats can work together in an otherwise “hyperpartisan time.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a new poll from NuggMD found that most cannabis consumers say that state-level hemp product bans that lawmakers are enacting in line with the planned federal recriminalization move are causing them to shift their purchases toward licensed marijuana businesses. The National Restaurant Association recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The post Senate Votes To Delay Hemp Ban, Giving Lawmakers More Time To Craft Regulations To Keep THC Products Legal appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

it is certainly wonderful along with meanful. it is certainly neat web site. Backlinks is incredibly valuable issue. you've got genuinely made it easier for some people whom pay a visit to web site and still provide these people usefull data. asiapowerball

Just booked through Delhi Escorts Service and was impressed by the smooth process. The lady was punctual, charming, and made the whole experience feel effortless. Perfect for anyone wanting reliable and classy companionship without any hassle in the capital.

These seductive Foreign Escort in Uttam Nagar are prepared to satisfy the desires of professionals, businesspeople, and anybody else seeking sexual fulfillment. It feels like bliss to be with them.

I'm glad I found this web site, I couldn't find any knowledge on this matter prior to.Also operate a site and if you are ever interested in doing some visitor writing for me if possible feel free to let me know, im always look for people to check out my web site. 1xbet apk arabitrend

Was specific about physical preferences and Sexy Escorts Delhi matched me perfectly. Curvy, brunette, exactly my type. No bait and switch or surprises. They actually listen to what you want. I felt like they cared about my satisfaction. Rare attention to detail in this business.

When your website or blog goes live for the first time, it is exciting. That is until you realize no one but you and your. toto

The popular point-of-sale and payments service Square says it will no longer allow CBD and other hemp-derived products to be sold on its platform, according to an email obtained by Marijuana Moment. The communication, sent to a business that uses Square, cited an upcoming change to federal law that will recriminalize many hemp products that were previously legalized by Congress. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. “Because of this change, selling CBD and hemp-derived products — online or in person — will no longer be permitted on Square’s platform,” the email said. “Your Square account remains open, and you can continue selling all of your non-CBD products on Square as usual, to the extent permitted under Square’s policies,” it continued. “Only the affected CBD/hemp items are impacted.” Businesses are being directed to “remove any CBD, hemp and hemp-derived items from your Square catalog (both in-person and online)” by October 15. “After that date, these items will no longer be permitted on Square platform,” the email said. “We know this is a significant change, and we want to give you as much time and support as possible to prepare.” A Square spokesperson told Marijuana Moment that “a new federal law taking effect later this year places new restrictions and requirements on hemp-derived products, including those containing CBD.” “To ensure compliance with this new law, we’re notifying impacted sellers and, where we’re able to, helping them update their catalogs so they can continue processing on Square,” they said. A now-deleted page on Square’s website previously pitched its services specifically to hemp businesses, saying it could help them “sell CBD online and in-store to reach every customer.” “Create a free online store and seamlessly accept payments for your CBD products. Or sync our software with your current site,” it said. “No matter how you run your CBD business, Square makes sure every part of it is protected.” The platform’s new prohibition on hemp products comes amid a growing push in Congress to delay, alter or reverse the forthcoming ban on hemp products. The U.S. Senate is expected to vote as soon as Friday on whether to extend the effective date of the hemp restrictions until December 11. A number of members of Congress from both parties have filed or are circulating legislation that would enact regulations for hemp products in lieu of broad prohibition. When asked whether Square would consider further revising its policies if the federal hemp product ban is delayed or reversed, the spokesperson said that “while we are constantly evaluating our policies and the broader compliance landscape to see if we can support more business types, we don’t have anything specific to share at this time.” Read the full CBD and hemp products email from Square below: Subject: [Action required] Important update about your Square account and CBD products We’re reaching out with an important update about a federal law change that affects businesses selling CBD and hemp-derived products. What’s changing A new federal law takes effect on November 12, 2026 that redefines which hemp and hemp-derived products are legal. Because of this change, selling CBD and hemp-derived products — online or in person — will no longer be permitted on Square’s platform. What this means for your business Your Square account remains open, and you can continue selling all of your non-CBD products on Square as usual, to the extent permitted under Square’s policies. Only the affected CBD/hemp items are impacted. What you need to do By October 15, 2026, please remove any CBD, hemp and hemp-derived items from your Square catalog (both in-person and online). After that date, these items will no longer be permitted on Square platform. If your business sells other, non-CBD products, no further action is needed — you’re all set to keep selling them. If you have a Square Loan Your outstanding Square Loan balance is unaffected by this change. Your remaining balance and your loan terms stay the same. Here’s how repayment continues: If you sell other, non-CBD products on Square: Nothing changes about how you repay. Your loan will continue to be repaid automatically as a percentage of your daily card sales, just as it does today. We know this is a significant change, and we want to give you as much time and support as possible to prepare. For more information or to contact us, visit our Support Center. The post Square Tells Businesses To Stop Selling Hemp And CBD Products In Light Of Upcoming Federal Ban appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Dr. Mehmet Oz, who leads the Centers for Medicare and Medicaid Services (CMS), is asking U.S. senators to reject an amendment that would keep a forthcoming ban on hemp products on track to take effect in November. “Passage of this amendment would undo significant gains that have been made to make clinically-appropriate full-spectrum hemp-derived CBD accessible to the senior citizens and individuals with disabilities that rely on the Medicare program for their healthcare,” Oz wrote in a letter to senators. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. On Sunday, leaders of the Senate Appropriations Committee released the text of a continuing resolution to extend funding for federal agencies through December 11, past the end of the current fiscal year on September 30. Included in the legislation are provisions that will also delay the planned prohibition on most hemp products until December 11—although there is a carve-out that will allow the immediately recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Sen. Ted Budd (R-NC) and several cosponsors have filed an amendment that seeks to strip the hemp ban delay provisions from the legislation, however, prompting pushback from the White House. In the new letter, Oz said he has “grave concern” that the amendment would undermine the administration’s initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “Above all, we must ensure that our policies and procedures are not inhibiting access to items and services that are helping patients manage the agony caused by insidious diseases like cancer, debilitating seizure disorders, and other chronic pain.” “In recent months, CMS has taken historic action to not only expand access to full-spectrum CBD, but do so in a way that ensures expanded access drives value for both patients and the Medicare program,” Oz wrote to senators. “We began this exercise with a simple principle: if an entity is accepting financial risk for the health of patients, they should have expanded flexibilities to invest in new care delivery models that they believe may help the health of those patients for whom they are financially at-risk.” “This is why, through the Center for Medicare and Medicaid Innovation (CMMI) we created critical flexibilities in three programs for risk-bearing medical entities to offer hemp products to improve symptom control. As a result, healthcare providers participating in the ACO Reach Model, the Enhancing Oncology Model, and the Long-term Enhance ACO Design (LEAD) Model will be able to offer coverage for up to $500 worth of hemp products each year, should those providers determine such coverage helps those patients. Similarly, we expanded the ability of Medicare Advantage plans to offer hemp-derived CBD products through special supplemental benefits for the chronically ill.” “As I have previously stated, CMS is committed to innovation that meets patients where they are while maintaining strong safeguards and clinical oversight,” the letter says. “It is for this reason that I am asking you to oppose S. Amendment 6733, which would rip away from millions of seniors and disabled Americans the opportunity to benefit from these new programs.” Oz said that officials “remain focused on preventing dangerous products from reaching Americans,” telling senators that they have his “commitment to continue to work with you on meeting our shared goals of ensuring patient access and protection of the public health.” Budd, for his part, argued in a Senate floor speech on Wednesday that widespread availability of intoxicating hemp products in states across the country is a “public health crisis” that threatens the lives of children, harms the workforce and undermines military readiness. “The intoxicating hemp industry wants to make a cheap dollar,” the senator said. “I am appalled at the well-oiled, slick lobbying machine, which is very well connected in this town, by the way, that has chosen to wage this surreptitious war against our efforts to protect American children.” Budd’s amendment garnered a lengthly list of cosponsors, including Sens. Pete Ricketts (R-NE), James Lankford (R-OK), Chuck Grassley (R-IA), Mike Rounds (R-SD), John Cornyn (R-TX), Mitch McConnell (R-KY), Bill Cassidy (R-LA), Tom Cotton (R-AR), Joni Ernst (R-IA) and Kevin Cramer (R-ND), among other senators. Several sources told Marijuana Moment this week that Trump personally called Budd in an attempt to get him to back off the push to keep the hemp ban on track for November, but a spokesperson for the senator later clarified that there was “not an explicit ask made to Sen. Budd to drop the amendment” by the president. The spokesperson said that the hemp issue “certainly came up” during what he described as a “very friendly” discussion between Budd and Trump that also touched on number of other topics. Separately, the White House pushed back on the idea that the president’s support for keeping hemp products legal is intended to benefit the son-in-law of Trump’s chief of staff, who owns businesses in the industry—with a spokesperson saying that the administration’s advocacy is in “the best interest of the American people” and is aimed at helping veterans and other people who use hemp products for medical purposes. During a “tense” meeting with Senate Republicans about the issue on Wednesday, White House Director of Legislative Affairs James Braid reportedly committed that there would be no further extensions of the hemp ban’s effective date if the current proposal was enacted into law. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Also this week, dueling coalitions of police, military veterans and industry groups sent letters pushing Congress in different directions on whether the planned federal recriminalization of hemp THC products should move forward as scheduled or be delayed. Additionally, a bipartisan coalition of 35 state and territory attorneys general sent a letter calling on Congress not to reverse the hemp THC product ban, saying that lawmakers’ move to enact the forthcoming prohibition “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.” In June, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded into December, but it did not have any provisions to alter the planned hemp product ban. Meanwhile, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products later this year. Until now, none of those proposals have gained traction with congressional leaders. For example, Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. Trump and White House officials have in recent weeks repeatedly pressed Congress to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) in June, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said in June, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” Read Oz’s hemp letter to senators below: The post Dr. Oz Asks Senators To Delay Hemp Product Ban So Seniors Can Get CBD Products Covered Through Medicare appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The fact that Texas is keeping marijuana illegal while also moving to restrict hemp THC products is “insane,” Democratic U.S. Senate candidate James Talarico says. It is also a form of corruption, he said in an interview with The Breakfast Club on Wednesday. “Think about what industries are most worried about THC products being readily available: Big Beer, Big Tobacco, right? And so they were the ones pushing this THC ban because it hurts their bottom line.” “And a lot of research shows that THC—cannabis—these products are safer and less addictive than than beer or tobacco,” Talarico, who currently serves as a state representative, said. “And so to me, this is a prime example of what corruption looks like when you’ve got big industries buying politicians and pushing bills that harm people, but benefit them financially.” The Democratic Senate candidate also noted that “a lot of young Texans, a lot of our veterans, they use THC products, for PTSD. Seniors use it.” THC is now virtually banned in Texas. Big Beer and Big Tobacco bought politicians to ban Delta-8 — because it's a threat to their profits. That is corruption. pic.twitter.com/LyrJbzjFAr — James Talarico (@jamestalarico) August 7, 2026 After Texas legalized hemp several years ago, it became “a booming industry in our state,” Talarico said. But more recently, Texas regulators have moved to ban certain hemp-derived THC cannabis products, including those containing delta-8 and delta-10 THC. Now classified as Schedule I drugs, possession is treated as a felony, carrying a punishment of 180 days to two years in prison and fines of up to $10,000. The restrictions are being challenged with a federal lawsuit filed by hemp companies. Talarico, for his part, said that criminalizing cannabis “is a gift to the drug cartels because Texans are going to keep smoking weed.” “They’re going to keep eating edibles,” he said. “They’re not going to stop because some politicians told them to. But now, instead of supporting a local small business, they’re going to go get it on the black market.” .@JamesTalarico: THC products are now virtually banned in the state of Texas. You have to have 3 DUIs to get a felony, and now just having Delta 8 can get you that felony. It’s insane. This is because of corruption. Think about what industries are most worried about THC products… pic.twitter.com/C5XTE5A0o1 — Team Talarico (@TeamTalaricoHQ) August 6, 2026 “Texans can’t afford the basics. They can’t get ahead no matter how hard they work or how much they save,” Talarico said. “And you’re going to ban a product that gives them a little bit of peace. It just it just drives me crazy. We should be trying to make people’s lives easier, not making their lives harder.” Talarico’s opponent for the Senate seat, state Attorney General Ken Paxton (R), is no fan of cannabis reform. As AG, he filed lawsuits to block several Texas cities from implementing local voter-approved laws to decriminalize marijuana. Image element courtesy of AnonMoos. The post Texas Banning Cannabis Is An ‘Insane’ Form Of Corruption That Benefits Big Beer, Big Tobacco And Drug Cartels, Talarico Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The U.S. Department of Veterans Affairs (VA) is launching a new clinical trial to investigate whether psilocybin can help military veterans who are struggling with treatment-resistant depression. The move follows VA’s recent announcement of a separate trial on MDMA-assisted therapy in treating veterans with severe mental health disorders, including PTSD and alcohol use disorder. The new psilocybin and depression research announced on Wednesday, titled “Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression,” or PIVOT, will also include veterans concurrent PTSD. The randomized, controlled trial—which comes on the heels of an executive order President Donald Trump signed in April with the aim of expediting psychedelic therapy access—will be conducted at five separate VA medical centers across Alabama, Oregon, Pennsylvania and Washington State. “Far too many veterans are living with mental health conditions that don’t respond to available treatments,” VA Secretary Doug Collins said in a press release. “Under President Trump, VA is pursuing all avenues to evaluate new treatments and offer meaningful relief for those who have worn the uniform. This clinical trial reflects another step toward this goal.” Veterans First VA is launching a clinical trial to evaluate the effectiveness and safety of psilocybin to treat major depression in Veterans, including those with concurrent post-traumatic stress disorder. Read: https://t.co/oLPIy2KKk7 pic.twitter.com/pbKene6JEf — VA Secretary Doug Collins (@SecVetAffairs) August 6, 2026 The psilocybin study will compare outcomes between two different dosage levels and will assess levels of depression before and after the psychedelic treatment, as well as tolerability of side effects. The research “reflects VA’s commitment to pursuing innovative solutions for veterans who have not responded to existing treatments,” the department said in a press release. Collins, the VA secretary, recently touted psychedelic therapy development at an event in Florida, saying that “we’re making massive progress in how we diagnose things, but also how we do new treatments, which in the past was more of a wait-and-see approach, and now we’re being more cutting-edge.” Last month, VA and the Department of Health and Human Services (HHS) launchd a new partnership to collaborate on research and development of psychedelic medicines to treat people struggling with serious mental health conditions. HHS Secretary Robert F. Kennedy Jr. said recently that the Trump administration is “very anxious” to create a pathway for access to psychedelics therapy and that top officials across federal agencies want to “get it out to the public as quickly as possible.” In an interview on the Joe Rogan Experience in February, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.” “Everybody in my agency…is very anxious to get a rule out there that will allow these kind of studies and will allow access under therapeutic settings, particularly [for] the military soldiers who have suffered these injuries to get access to these products,” the HHS secretary said. “We’re working through that process now. We’re all working on it and trying to make it happen.” “I think that we’re going to get it done,” he said. Last June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” Collins disclosed last year that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Photo courtesy of Mark Groeneveld. The post VA Launches New Study Using Psilocybin To Treat Veterans With Depression And PTSD appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Making the jump in your everyday vibe and, you know, your social calendar in a huge metropolis usually means hunting down the best leisure options you can find. And if you have refined tastes, then using a top tier VIP Delhi Escort Service is basically the most direct route. There s this real, almost obsessive commitment to discretion, along with the stunning beauty and sharp minded presence of the companions, that together give you this elite kind of night out that keeps going beyond expectations, like every time. By the end you feel fully coddled, genuinely pampered.

Groups on both sides push Congress over hemp; NY gov signs marijuana farmers’ market bill; Study: CBD for athlete recovery Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Sens. Ted Budd (R-NC) and Pete Ricketts (R-NE) took to the Senate floor to urge colleagues not to delay the federal recriminalization of hemp THC products—raising alarm about kids access’ and alleged harms to the workforce and military readiness. Groups on both sides of the hemp debate—Veterans of Foreign Wars of the United States, Wine and Spirits Wholesalers of America, National Association of Convenience Stores and the National Sheriffs’ Association—sent letters pressing Congress about whether or not to delay a scheduled ban on hemp THC products. New York Gov. Kathy Hochul (D) signed a bill allowing marijuana microbusinesses to fully participate in cannabis farmers’ markets and pop-up events—giving them “a real chance to succeed in New York’s legal cannabis market.” A new scientific review concluded that “CBD appears to have beneficial properties for sports recovery” as well as “potentially performance-enhancing properties in athletes.” “CBD has demonstrated anti-inflammatory, neuroprotective, anxiolytic, and analgesic properties, which are potentially beneficial for athlete recovery.” Aaron Edelheit of Mindset Capital argues in a new Marijuana Moment op-ed that cannabis companies that are joining forces with prohibitionists to convince lawmakers to ban hemp THC products are engaged in a “self-defeating campaign” that is “helping those who have been at war with cannabis for decades.” “By aligning themselves with the prohibitionists they are now fighting the president of the United States.” / FEDERAL Vice President JD Vance was reportedly expected to discuss issues around federally recriminalizing hemp THC products with Republican senators. The Substance Abuse and Mental Health Services Administration tweeted, “Marijuana use during pregnancy can be harmful to a baby’s health and cause many serious problems. Find out why avoiding marijuana during pregnancy and breastfeeding can give your baby a healthier start in life.” The Congressional Research Service included an analysis of hemp provisions in a report about the Farm Bill. Rep. Andy Harris (R-MD) tweeted, “We have to stop poisoning our children for the profit of intoxicating hemp merchants.” / STATES California Gov. Gavin Newsom (D) touted enforcement efforts that have seized more than $168 million in illicit cannabis and tobacco products since 2019 A former advisor to Oklahoma Gov. Kevin Stitt (R) was implicated by a co-defendant of allegedly helping out-of-state clients circumvent state rules on medical cannabis business ownership. Pennsylvania’s attorney general sent a press release about a letter he signed asking Congress not to delay the federal recriminalization of hemp THC products. Colorado regulators adopted changes to marijuana tax rules. Delaware’s top marijuana regulator provided an overview of the state’s first year of legal recreational sales. A Massachusetts marijuana regulator discussed next steps for social consumption businesses. U.S. Virgin Islands regulators approved marijuana manufacturing business license applicants to advance to the next stage of the process. New Jersey regulators published tips for doctors about how to discuss cannabis with their patients. Montana regulators sent a newsletter with various cannabis updates. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Newton, Massachusetts is being ordered by a state court to repay $2.4 million in “community impact fees” paid by marijuana businesses. Los Angeles, California regulators sent a monthly cannabis newsletter. / INTERNATIONAL Uruguayan officials are increasing legal marijuana prices. / SCIENCE & HEALTH A study of mice provided “novel in vivo evidence supporting the potential of cannabinoid-based formulations as adjunctive therapeutic approaches for [estrogen receptor]-positive breast cancer.” A study found that “chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of” late infantile neuronal ceroid lipofuscinosis. / ADVOCACY, OPINION & ANALYSIS Concerned Women for America tweeted, “Congress voted in November 2025 to ban dangerous hemp-derived THC products like Delta 8 from the market, yet now they may vote to delay that ban via an unrelated government funding bill. Thank you to @SenTedBuddNC and @SenatorRicketts for fighting to remove that provision from the continuing resolution. Congress should vote on their amendment and CWALAC will score in favor of it.” / BUSINESS Curaleaf Holdings, Inc. reported quarterly net revenue of $340.1 million. Cresco Labs Inc. reported quarterly net revenue of $173.3 million. Cronos Group Inc. reported quarterly net revenue of $53 million. Native Roots is closing a Denver, Colorado facility and laying off 141 employees. High Tide Inc. closed senior secured credit facilities in the aggregate principal amount of C$40 million. / CULTURE The Shambhala music festival features on-site testing of drugs for contaminants. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Senators step up push for hemp THC ban in November (Newsletter: August 7, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net